POET Technologies Races to Scale with $400M Cash Injection as Losses Deepen and Short Sellers Circle

Despite $400M raise, POET's $9M/quarter cash burn & missed revenue targets raise doubts; short seller attack, CFO departure add uncertainty.

The math at POET Technologies is stark: a company burning through nearly $9 million in operating cash each quarter, generating barely half a million dollars in revenue, yet sitting on a cash pile of $429 million after a blockbuster capital raise. The gap between ambition and execution has never been wider — and investors are trying to decide whether that gap spells opportunity or danger.

Revenue more than tripled year-over-year to $503,389 in the first quarter, but that figure landed far below the $2.2 million analysts had penciled in. The company swung from a prior-year profit of $6.3 million to a net loss of $12.3 million. Adjusted losses came in at $0.08 per share, wider than the $0.05 consensus estimate. Research and development spending held steady at $4.5 million, underlining the heavy investment required before the photonics playbook can generate meaningful commercial returns.

That spending spree is now fuelled by a fresh $400 million from a single institutional investor. The package consists of 19.05 million common shares and warrants for an equal number of additional shares, sold at a combined price of $21 per unit. The warrants carry an exercise price of $26.15 and a three-year maturity. The placement is expected to close around May 18, lifting the company's total equity to $448.6 million, up from $183.8 million at year-end. Total assets reached $461.8 million.

The cash is earmarked for an aggressive expansion. New chief operating officer Sandeep Kumar is charged with building out manufacturing capacity in Malaysia, targeting optical components for AI networks and hyperscale data centers. The company also plans targeted acquisitions and continued research. A key strategic partner is Lumilens, with whom POET is developing advanced pluggable modules and integrated optics solutions. First samples are slated for the end of 2026, with mass production to follow in 2027.

Yet even as the balance sheet bulks up, commercial credibility is being questioned. Short seller Night Market Research announced a position against the stock, pointing to cancelled orders from Marvell Technology and casting doubt on a Lumilens order. The firm claimed that seven contacted POET partners described their relationships as "insignificant or dead." The short report landed just after the stock had swung wildly — down 22.4% on Friday following a 43% surge the previous day, then recovering about 11% in pre-market trading Monday.

The Nvidia factor adds another layer of volatility. POET shares have repeatedly moved on the chip giant's mentions of photonics technology, even though no direct business relationship exists. Traders are watching Nvidia's upcoming earnings as a potential catalyst for the broader photonics trade.

Against this choppy backdrop, a leadership change adds uncertainty. Chief financial officer Thomas Mika, a ten-year veteran of the company, announced he will step down. Mika oversaw the financial transformation that has left POET with a fortress-like balance sheet but also with the immense challenge of converting cash into customers.

The stock traded at $20.57 early Monday, barely below its recent highs. Investors now face a dual narrative: on one hand, a company with nearly half a billion dollars in cash and a clear roadmap to scale optical components for the AI boom; on the other, a business whose revenue doesn't yet cover a tenth of its quarterly cash burn, whose partner network faces serious scrutiny, and whose CEO must prove that the technology can become a real business. The next few quarters will show whether the money can buy more than time.